Camilla L. Duus

Herning, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Renal effects of short-term ketone monoester supplementation in healthy adults: A randomized, placebo-controlled study.

Renal effects of short-term ketone monoester supplementation in healthy adults: A randomized, placebo-controlled study.

Journal: Physiological reports

Published: January 31, 2026

Apixaban Concentrations and Effects on Coagulation in Patients With Nephrotic Syndrome.

Apixaban Concentrations and Effects on Coagulation in Patients With Nephrotic Syndrome.

Journal: Kidney medicine

Published: December 03, 2025

Dietary Sodium Reduction Reveals Aldosterone Dysregulation in Patients With Essential Hypertension.

Dietary Sodium Reduction Reveals Aldosterone Dysregulation in Patients With Essential Hypertension.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: October 27, 2025

Sodium reduction is the key ingredient in dietary treatment of hypertension - a randomized controlled trial on sodium, potassium and nitrate.

Sodium reduction is the key ingredient in dietary treatment of hypertension - a randomized controlled trial on sodium, potassium and nitrate.

Journal: Journal of human hypertension

Published: June 10, 2025

Empagliflozin and fluid balance: results from the SiRENA project.

Empagliflozin and fluid balance: results from the SiRENA project.

Journal: Clinical kidney journal

Published: May 05, 2025

Alterations in Coagulation and Endothelial Function in Nephrotic Syndrome: A Multicenter, Cross-Sectional Analysis.

Alterations in Coagulation and Endothelial Function in Nephrotic Syndrome: A Multicenter, Cross-Sectional Analysis.

Journal: Kidney360

Published: March 17, 2025

The effects of empagliflozin on systemic haemodynamic function: three randomized, placebo-controlled trials.

The effects of empagliflozin on systemic haemodynamic function: three randomized, placebo-controlled trials.

Journal: Journal of hypertension

Published: October 22, 2024

Renal clearance estimated by rubidium-82 positron emission tomography/computed tomography and technetium-99m-mercaptoacetyltriglycine clearance infusion technique.

Renal clearance estimated by rubidium-82 positron emission tomography/computed tomography and technetium-99m-mercaptoacetyltriglycine clearance infusion technique.

Journal: Clinical physiology and functional imaging

Published: September 20, 2024

SGLT2 inhibition improves endothelium-independent vasodilatory function in type 2 diabetes: A double-blind, randomized, placebo-controlled crossover trial.

SGLT2 inhibition improves endothelium-independent vasodilatory function in type 2 diabetes: A double-blind, randomized, placebo-controlled crossover trial.

Journal: Diabetes, obesity & metabolism

Published: September 11, 2024

Randomized, Placebo-Controlled Trial on the Renal and Systemic Hemodynamic Effects of Empagliflozin.

Randomized, Placebo-Controlled Trial on the Renal and Systemic Hemodynamic Effects of Empagliflozin.

Journal: Kidney international reports

Published: August 07, 2024

Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial.

Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial.

Journal: Journal of the American Heart Association

Published: June 06, 2024

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

Journal: JMIR research protocols

Published: January 04, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026